ATII - Archimedes Tech SPA... Stock Analysis | Stock Taper
Logo
Archimedes Tech SPAC Partners II Co. Ordinary Shares

ATII

Archimedes Tech SPAC Partners II Co. Ordinary Shares NASDAQ
$10.53 -0.75% (-0.08)

Market Cap $311.58 M
52w High $10.70
52w Low $9.96
P/E 0
Volume 9.30K
Outstanding Shares 29.59M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $159.84K $2.4M 0% $0.08 $-159.84K
Q2-2025 $0 $130.36K $2.36M 0% $0.08 $-130.36K
Q1-2025 $0 $146.66K $1.16M 0% $0.06 $-146.66K
Q4-2024 $0 $23 $-23 0% $-0 $0
Q3-2024 $0 $13K $-55.7 0% $-0 $-55.7

What's going well?

The company is generating steady profits from interest income, with net income and EPS both ticking up slightly. Lower share count also helped boost per-share results.

What's concerning?

ATII still has no revenue from its core business and operating losses are growing. Profitability depends entirely on interest income, which may not be sustainable long-term.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.41M $239.27M $8.18M $231.09M
Q2-2025 $1.76M $236.9M $8.21M $228.69M
Q1-2025 $1.86M $234.55M $8.22M $226.33M
Q4-2024 $0 $429.69K $483.39K $-53.7K
Q3-2024 $0 $337.31K $368.01K $-30.7K

What's financially strong about this company?

ATII has no debt, a very high current ratio, and nearly all its assets are in liquid investments. Shareholder equity is strong and growing, making the company financially stable.

What are the financial risks or weaknesses?

Cash is a tiny portion of total assets, and the company has negative retained earnings, meaning it has not been profitable over its lifetime. There is little physical infrastructure or diversification in asset types.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $2.4M $-344.58K $231.15M $-11.16K $-355.74K $-344.58K
Q2-2025 $2.36M $-95.39K $0 $-2.93K $-98.31K $-95.39K
Q1-2025 $1.16M $-254.01K $-231.15M $233.27M $1.86M $-254.01K
Q4-2024 $-23 $0 $0 $0 $0 $0
Q3-2024 $-55.7K $0 $0 $0 $0 $0

What's strong about this company's cash flow?

No debt and no dilution from new shares or stock-based compensation. The company still has over $1.4M in cash and minimal capital spending needs.

What are the cash flow concerns?

Operations are consistently burning cash, and the burn rate is rising. If this continues, the company could run out of cash within a year.

5-Year Trend Analysis

A comprehensive look at Archimedes Tech SPAC Partners II Co. Ordinary Shares's financial evolution and strategic trajectory over the past five years.

+ Strengths

ATII’s main strengths are qualitative rather than financial: an experienced sponsor team with a demonstrated ability to close at least one notable tech transaction, and a clear focus on high-growth areas such as AI and cloud-based solutions. The structure as a SPAC provides a ready-made path for a private tech firm to access public capital markets, and the absence of long-term debt and goodwill reduces some structural encumbrances if a turnaround or recapitalization is needed.

! Risks

The risk profile is high. Financially, the company shows negative equity, no cash, no current assets, and obligations that outstrip its asset base, all of which underline liquidity and solvency concerns. Operationally, there is no active business, no revenue, and no visible pipeline of deals. Strategically, ATII faces time pressure, intense competition for quality tech targets, and the possibility that it may be forced into a suboptimal merger or a wind-down if conditions do not improve. Regulatory and market fatigue around SPACs add another layer of uncertainty.

Outlook

The outlook is highly contingent and binary in nature. In the near term, balance sheet weakness and the absence of operating activity suggest a challenging environment: the company must secure capital support and a transaction to avoid prolonged distress. Over the medium term, outcomes will depend almost entirely on whether ATII can identify and close a high-quality tech merger that brings real revenue, cash flow, and defensible innovation into the listed entity. Until such a deal is announced and detailed, any forward view remains speculative and should be framed around execution, deal quality, and balance sheet repair rather than current financial performance.